After an initial description of some of the important conceptual steps in the establishment of purinergic signalling, the talk will focus on some of the exciting developments relating to purinergic pathophysiology and potential therapeutic applications. There will be discussion of the long-term trophic effects of purines and pyrimidines in blood vessel remodelling in restenosis; plasticity of purinergic cotransmission of diseased urinary bladder and hypertensive rats; sperm motility in IVF; purinergic mechanosensory transduction in visceral pain and the role of spinal microglial purinoceptors in neuropathic pain; the potential for P2X7 receptor antagonists in osteoporosis and kidney failure and P2Y2 receptor agonists for dry eye and cystic fibrosis. Further, there is a growing literature about the roles of purinergic signalling in disorders of the central nervous system; and the role of ATP in the treatment of cancer. Finally, a novel hypothesis will be presented for the involvement of purinergic signalling in acupuncture.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Autonomic Neuroscience: Basic and Clinical
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2010 Published by Elsevier Inc.